amylin vs glp-1 BioCentury Amylin: From Mode of Action

Heres why delivery mattersand when injections may help.

It's a fillip for new Novo Nordisk chief executive Mike Doustdar, who took the helm last year with a clear remit to defend the GLP-1-based weight loss and diabetes business from rivals like Eli Lilly, as well as knock-off versions of semaglutide that sidestep the company's intellectual property (IP).

All doses of FDA-approved Wegovy, the most widely prescribed and studied GLP-1 for weight loss, are now accessible to patients of select telehealth providers...

Address obesity and all comorbidities.

Methods In this open-label, single-center, casecontrol pilot study, patients with IIH (pwIIH) and a body mass index (BMI) of30 kg/m2 were offered to receive a GLP-1-RA (semaglutide, liraglutide) in addition to the usual care weight management (UCWM)